Blesch A - Search Results

1

A dual promoter lentiviral vector for the in vivo evaluation of gene therapeutic approaches to axon regeneration after spinal cord injury.

Löw K, Blesch A, Herrmann J, Tuszynski MH. Löw K, et al. Among authors: blesch a. Gene Ther. 2010 May;17(5):577-91. doi: 10.1038/gt.2010.14. Epub 2010 Mar 4. Gene Ther. 2010. PMID: 20200564

2

Ex vivo gene therapy for Alzheimer's disease and spinal cord injury.

Blesch A, Tuszynski M. Blesch A, et al. Clin Neurosci. 1995-1996;3(5):268-74. Clin Neurosci. 1995. PMID: 8914793 Review.

3

Functional characterization of NGF-secreting cell grafts to the acutely injured spinal cord.

Tuszynski MH, Murai K, Blesch A, Grill R, Miller I. Tuszynski MH, et al. Among authors: blesch a. Cell Transplant. 1997 May-Jun;6(3):361-8. doi: 10.1177/096368979700600318. Cell Transplant. 1997. PMID: 9171168

4

Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury.

Grill R, Murai K, Blesch A, Gage FH, Tuszynski MH. Grill R, et al. Among authors: blesch a. J Neurosci. 1997 Jul 15;17(14):5560-72. doi: 10.1523/JNEUROSCI.17-14-05560.1997. J Neurosci. 1997. PMID: 9204937 Free PMC article.

5

Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells.

Grill RJ, Blesch A, Tuszynski MH. Grill RJ, et al. Among authors: blesch a. Exp Neurol. 1997 Dec;148(2):444-52. doi: 10.1006/exnr.1997.6704. Exp Neurol. 1997. PMID: 9417824

6

Neurotrophin gene therapy in CNS models of trauma and degeneration.

Blesch A, Grill RJ, Tuszynski MH. Blesch A, et al. Prog Brain Res. 1998;117:473-84. doi: 10.1016/s0079-6123(08)64033-9. Prog Brain Res. 1998. PMID: 9932426 Review. No abstract available.

7

Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury.

Blesch A, Uy HS, Grill RJ, Cheng JG, Patterson PH, Tuszynski MH. Blesch A, et al. J Neurosci. 1999 May 1;19(9):3556-66. doi: 10.1523/JNEUROSCI.19-09-03556.1999. J Neurosci. 1999. PMID: 10212315 Free PMC article.

8

Nerve growth factor-hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1.

Weidner N, Blesch A, Grill RJ, Tuszynski MH. Weidner N, et al. Among authors: blesch a. J Comp Neurol. 1999 Nov 1;413(4):495-506. doi: 10.1002/(sici)1096-9861(19991101)413:4<495::aid-cne1>3.0.co;2-z. J Comp Neurol. 1999. PMID: 10495438

9

Neurite outgrowth can be modulated in vitro using a tetracycline-repressible gene therapy vector expressing human nerve growth factor.

Blesch A, Uy HS, Diergardt N, Tuszynski MH. Blesch A, et al. J Neurosci Res. 2000 Feb 1;59(3):402-9. doi: 10.1002/(SICI)1097-4547(20000201)59:3<402::AID-JNR14>3.0.CO;2-Q. J Neurosci Res. 2000. PMID: 10679776

10

Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression.

Blesch A, Conner JM, Tuszynski MH. Blesch A, et al. Gene Ther. 2001 Jun;8(12):954-60. doi: 10.1038/sj.gt.3301480. Gene Ther. 2001. PMID: 11426336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page